Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-002411-27Phase 4Completed
Phase 4, single-arm trial of escitalopram in major depressive disorder (MDD), sponsored by UPC KU Leuven. Primary endpoints: Change in geriatric depression, Change in cognitive functioning and 1 more. Started Sep 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-002411-27.